Yi Zeng, Ph.D.
Affiliations: | 2003 | University of Arizona, Tucson, AZ |
Area:
Immunology, OncologyGoogle:
"Yi Zeng"Parents
Sign in to add mentor| Emmanuel Katsanis | grad student | 2003 | University of Arizona | |
| (Optimizing immunity against BCR -ABL positive leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Molina MS, Stokes J, Hoffman EA, et al. (2020) Bendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3. Frontiers in Immunology. 11: 1410 |
| Stokes J, Hoffman EA, Molina MS, et al. (2020) Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia. Oncoimmunology. 9: 1758011 |
| Stokes J, Hoffman EA, Molina MS, et al. (2018) Bendamustine with total body irradiation limits murine graft-versus-host disease in part through effects on myeloid-derived suppressor cells. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation |
| Katsanis E, Sapp LN, Varner N, et al. (2018) Haploidentical bone marrow transplantation with post-transplant cyclophosphamide/bendamustine in pediatric and young adult patients with hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation |
| Sun L, Hao Y, Wang Z, et al. (2018) Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines. Viruses. 10 |
| Zeng Y, Hahn S, Stokes J, et al. (2017) Pak2 regulates myeloid-derived suppressor cell development in mice. Blood Advances. 1: 1923-1933 |
| Zeng Y, Katsanis E. (2017) Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantation. Bone Marrow Transplantation |
| Katsanis E, Sapp LN, Pelayo-Katsanis L, et al. (2016) Alternative Donor Hematopoietic Cell Transplantation Conditioned With Myeloablative Busulfan, Fludarabine, and Melphalan is Well Tolerated and Effective Against High-risk Myeloid Malignancies. Journal of Pediatric Hematology/Oncology |
| Stokes J, Hoffman EA, Zeng Y, et al. (2016) Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation. British Journal of Haematology |
| Zeng Y, Katsanis E. (2015) The complex pathophysiology of acquired aplastic anaemia. Clinical and Experimental Immunology. 180: 361-70 |